Infant Viral Exposure and Risk of Childhood Asthma

婴儿病毒暴露和儿童哮喘风险

基本信息

  • 批准号:
    7273665
  • 负责人:
  • 金额:
    $ 4.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of this research application is to explore the influence of viral exposure intensity during infancy on the development of asthma by age five years, and to identify critical time periods in infancy during which seasonal respiratory viral infection increases susceptibility to develop childhood asthma. Using the established research infrastructure of the Tennessee Medicaid claims data linked to birth certificates, we will determine the critical age periods associated with high risk of developing childhood asthma using a training dataset. The relationship of viral exposure intensity and infant age on development of childhood asthma will be examined in a separate test dataset. Furthermore, the potential interaction effects between infant viral exposure and maternal asthma (familial risk factor) and maternal smoking (environmental risk factor) will be examined. Restricted cubic splines will be applied to determine the smooth relationship between viral exposure age, intensity and the development of childhood asthma. The implications of this research relate to the potential for identifying critical time periods during which preventing infection could prevent or alter the phenotypic expression of asthma in predisposed hosts.
描述(由申请人提供):本研究申请的目的是探索婴儿时期病毒暴露强度对5岁前哮喘发展的影响,并确定婴儿时期季节性呼吸道病毒感染增加儿童哮喘易感性的关键时期。利用与出生证明相关的田纳西州医疗补助索赔数据的既定研究基础设施,我们将使用训练数据集确定与儿童哮喘高风险相关的关键年龄期。病毒暴露强度和婴儿年龄对儿童哮喘发展的关系将在一个单独的测试数据集中进行检验。此外,还将研究婴儿病毒暴露与母亲哮喘(家族危险因素)和母亲吸烟(环境危险因素)之间的潜在相互作用。限制三次样条将用于确定病毒暴露年龄,强度和儿童哮喘发展之间的平滑关系。这项研究的意义与确定预防感染可以预防或改变易感宿主哮喘表型表达的关键时期的潜力有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PINGSHENG WU其他文献

PINGSHENG WU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PINGSHENG WU', 18)}}的其他基金

Electronic cigarette use during pregnancy and the impact on newborn metabolic profile and perinatal health outcomes
怀孕期间电子烟的使用及其对新生儿代谢特征和围产期健康结果的影响
  • 批准号:
    10220499
  • 财政年份:
    2021
  • 资助金额:
    $ 4.88万
  • 项目类别:
Electronic cigarette use during pregnancy and the impact on newborn metabolic profile and perinatal health outcomes
怀孕期间电子烟的使用及其对新生儿代谢特征和围产期健康结果的影响
  • 批准号:
    10395595
  • 财政年份:
    2021
  • 资助金额:
    $ 4.88万
  • 项目类别:
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome
RSV 免疫预防对唐氏综合症儿童短期和长期呼吸道疾病发病率的有效性
  • 批准号:
    10398259
  • 财政年份:
    2019
  • 资助金额:
    $ 4.88万
  • 项目类别:
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome
RSV 免疫预防对唐氏综合症儿童短期和长期呼吸道疾病发病率的有效性
  • 批准号:
    10552583
  • 财政年份:
    2019
  • 资助金额:
    $ 4.88万
  • 项目类别:
Antibiotic timing, spectrum, and cumulative dose during pregnancy and infancy on risk of asthma
妊娠期和婴儿期抗生素使用时机、范围和累积剂量对哮喘风险的影响
  • 批准号:
    9170444
  • 财政年份:
    2016
  • 资助金额:
    $ 4.88万
  • 项目类别:
RSV immunoprophylaxis impact on RSV morbidity & asthma in healthy preterm infants
RSV 免疫预防对 RSV 发病率的影响
  • 批准号:
    8757597
  • 财政年份:
    2014
  • 资助金额:
    $ 4.88万
  • 项目类别:
RSV immunoprophylaxis impact on RSV morbidity & asthma in healthy preterm infants
RSV 免疫预防对 RSV 发病率的影响
  • 批准号:
    8901292
  • 财政年份:
    2014
  • 资助金额:
    $ 4.88万
  • 项目类别:
Real-world patient responsiveness & safety of long-acting beta agonists in asthma
真实世界的患者反应
  • 批准号:
    8641889
  • 财政年份:
    2013
  • 资助金额:
    $ 4.88万
  • 项目类别:
Real-world patient responsiveness & safety of long-acting beta agonists in asthma
真实世界的患者反应
  • 批准号:
    9294369
  • 财政年份:
    2013
  • 资助金额:
    $ 4.88万
  • 项目类别:
Statistical methods for comparative treatment effectiveness using claims data
使用索赔数据比较治疗效果的统计方法
  • 批准号:
    8037531
  • 财政年份:
    2010
  • 资助金额:
    $ 4.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了